These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19416878)

  • 1. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.
    Derfuss T; Parikh K; Velhin S; Braun M; Mathey E; Krumbholz M; Kümpfel T; Moldenhauer A; Rader C; Sonderegger P; Pöllmann W; Tiefenthaller C; Bauer J; Lassmann H; Wekerle H; Karagogeos D; Hohlfeld R; Linington C; Meinl E
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8302-7. PubMed ID: 19416878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray-matter injury in multiple sclerosis.
    Rudick RA; Trapp BD
    N Engl J Med; 2009 Oct; 361(15):1505-6. PubMed ID: 19812410
    [No Abstract]   [Full Text] [Related]  

  • 3. The gray aspects of white matter disease in multiple sclerosis.
    Steinman L
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8083-4. PubMed ID: 19451620
    [No Abstract]   [Full Text] [Related]  

  • 4. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R; Gerritsen W; Heijmans N; Amor S
    Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untapped targets in multiple sclerosis.
    Meinl E
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S12-5. PubMed ID: 22206760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
    Bernard CC; Johns TG; Slavin A; Ichikawa M; Ewing C; Liu J; Bettadapura J
    J Mol Med (Berl); 1997 Feb; 75(2):77-88. PubMed ID: 9083925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contactin-2/TAG-1, active on the front line for three decades.
    Masuda T
    Cell Adh Migr; 2017 Sep; 11(5-6):524-531. PubMed ID: 28135886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS.
    Gerhards R; Pfeffer LK; Lorenz J; Starost L; Nowack L; Thaler FS; Schlüter M; Rübsamen H; Macrini C; Winklmeier S; Mader S; Bronge M; Grönlund H; Feederle R; Hsia HE; Lichtenthaler SF; Merl-Pham J; Hauck SM; Kuhlmann T; Bauer IJ; Beltran E; Gerdes LA; Mezydlo A; Bar-Or A; Banwell B; Khademi M; Olsson T; Hohlfeld R; Lassmann H; Kümpfel T; Kawakami N; Meinl E
    Acta Neuropathol Commun; 2020 Nov; 8(1):207. PubMed ID: 33256847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
    Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.
    von Büdingen HC; Tanuma N; Villoslada P; Ouallet JC; Hauser SL; Genain CP
    J Clin Immunol; 2001 May; 21(3):155-70. PubMed ID: 11403222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofascin as a novel target for autoantibody-mediated axonal injury.
    Mathey EK; Derfuss T; Storch MK; Williams KR; Hales K; Woolley DR; Al-Hayani A; Davies SN; Rasband MN; Olsson T; Moldenhauer A; Velhin S; Hohlfeld R; Meinl E; Linington C
    J Exp Med; 2007 Oct; 204(10):2363-72. PubMed ID: 17846150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral autoimmunity in multiple sclerosis.
    Meinl E; Derfuss T; Krumbholz M; Pröbstel AK; Hohlfeld R
    J Neurol Sci; 2011 Jul; 306(1-2):180-2. PubMed ID: 20817206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
    Berer K; Mues M; Koutrolos M; Rasbi ZA; Boziki M; Johner C; Wekerle H; Krishnamoorthy G
    Nature; 2011 Oct; 479(7374):538-41. PubMed ID: 22031325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice.
    Kishore A; Kanaujia A; Nag S; Rostami AM; Kenyon LC; Shindler KS; Das Sarma J
    Biomed Res Int; 2013; 2013():589048. PubMed ID: 24083230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantigens and autoantibodies in multiple sclerosis.
    Mirshafiey A; Kianiaslani M
    Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):292-303. PubMed ID: 23996705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.